GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals: Board Recommends Rs. 0.01 Dividend and Allots 17.35 Lakh Shares
DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 07 May 2026, 10:43 PM IST  ·  BSE ID: e289e5cc-3792-4656-9054-ad6ba02d4e50
View Original BSE Filing (PDF)
💡
In Simple Terms
The company declared a small dividend and issued new shares to promoters after they converted their warrants, increasing the company's capital.
🤖 AI Summary
  • Board recommended a final dividend of Rs. 0.01 (1%) per equity share for FY2025-26.
  • Approved allotment of 17,35,000 fully paid-up equity shares to promoters Dakshesh Shah and Parshva Texchem India Private Limited.
  • Allotment of shares made for cash, raising Rs. 4,42,42,500/-.
  • Company's paid-up equity capital increased from Rs. 43,78,79,440/- to Rs. 43,96,14,440/-.
  • 29,08,000 warrants remain outstanding after this conversion.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Final Dividend per equity share
Rs. 0.01
Number of equity shares allotted
17,35,000
Funds raised from warrant conversion
Rs. 4,42,42,500/-
Previous Paid-up equity capital
Rs. 43,78,79,440/-
New Paid-up equity capital
Rs. 43,96,14,440/-
Total outstanding warrants
29,08,000
🏢 How This Affects the Company
💰
Financial Impact
The allotment of 17,35,000 equity shares generated Rs. 4,42,42,500/- in cash from promoters. The paid-up equity capital increased by Rs. 1,73,50,000/-.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must approve the final dividend recommendation at the ensuing Annual General Meeting.
👤
Who Is Affected
All equity shareholders of Re. 1/- each are eligible for the recommended final dividend of Rs. 0.01 per share. The allotment of 17,35,000 equity shares to promoters increases the total outstanding shares.
🔍
Management Signal
The board's decision to recommend a dividend and convert warrants signals a focus on capital augmentation and shareholder returns.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Annual General Meeting date for dividend approval.
Record date announcement for the recommended dividend.
Future filings on remaining 29,08,000 outstanding warrant conversions.
LOW RISK The filing reports positive financial actions with no immediate risks identified.
💡 Investor Takeaway
Shukra Pharmaceuticals' board recommended a final dividend of Rs. 0.01 (1%) per equity share for FY2025-26. Additionally, 17,35,000 equity shares were allotted to promoters for Rs. 4,42,42,500/-, increasing the paid-up equity capital from Rs. 43,78,79,440/- to Rs. 43,96,14,440/-.
⚖️ Strengths & Concerns

✅ Positives

  • Share warrant conversion brought in Rs. 4,42,42,500/- in cash, strengthening the company's capital base.
  • Recommendation of a Rs. 0.01 (1%) final dividend for FY2025-26 indicates a return to shareholders.
📅 Company Track Record
No previous filings found for Shukra Pharmaceuticals Ltd, thus limited historical context is available. The company's recent actions include a dividend recommendation and capital increase.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.